rolipram and chlorine
rolipram has been researched along with chlorine in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bagorda, A; Cardone, R; Casavola, V; Debellis, L; Guerra, L; Jacobson, KA; Li, AH; Reshkin, SJ | 1 |
| Blanchard, E; Conti, M; Finkbeiner, WE; Gruenert, DC; Lao, A; Mika, D; Namkung, W; Richter, W; Scheitrum, C; Verkman, AS; Xie, M; Zlock, L | 1 |
| Clancy, JP; Cobb, BR; Fan, L; Kovacs, TE; Sorscher, EJ | 1 |
| Chang, W; Chen, J; Hoyle, GW; Pathak, YV; Rando, RJ; Schlueter, CF | 1 |
| Carson, KH; Chen, J; Hoyle, GW; Humphrey, DM; Mo, Y; Niño, JA; Rawson, G; Schlueter, CF | 1 |
Other Studies
5 other study(ies) available for rolipram and chlorine
| Article | Year |
|---|---|
Activation of A(3) adenosine receptor induces calcium entry and chloride secretion in A(6) cells.
Topics: Adenosine; Animals; Calcium; Calcium Signaling; Cell Line; Chlorides; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dihydropyridines; Electric Conductivity; Epithelial Cells; Kidney; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyridines; Receptor, Adenosine A3; Receptors, Purinergic P1; Rolipram; Signal Transduction | 2000 |
Anchored PDE4 regulates chloride conductance in wild-type and ΔF508-CFTR human airway epithelia.
Topics: Amiloride; Cells, Cultured; Chlorides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelium; Humans; Immunoprecipitation; Quinolones; Respiratory Mucosa; Rolipram | 2014 |
Adenosine receptors and phosphodiesterase inhibitors stimulate Cl- secretion in Calu-3 cells.
Topics: Adenosine Deaminase; Anions; Cell Line; Chlorine; Cilostazol; Colforsin; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Electrophysiology; Epithelium; Glyburide; Humans; Hypoglycemic Agents; Milrinone; Mutation; Papaverine; Phosphodiesterase Inhibitors; Piperazines; Purines; Receptors, Purinergic P1; Rolipram; Sildenafil Citrate; Sulfones; Tetrazoles; Time Factors | 2003 |
Inhibition of chlorine-induced lung injury by the type 4 phosphodiesterase inhibitor rolipram.
Topics: Acute Lung Injury; Administration, Intranasal; Animals; Bronchial Hyperreactivity; Chlorine; Cyclic AMP; Emulsions; Inhalation Exposure; Injections, Intramuscular; Injections, Intraperitoneal; Mice; Nanoparticles; Phosphodiesterase 4 Inhibitors; Rolipram | 2012 |
Development and assessment of countermeasure formulations for treatment of lung injury induced by chlorine inhalation.
Topics: Acute Lung Injury; Animals; Budesonide; Chemistry, Pharmaceutical; Chlorine; Diterpenes; Drug Carriers; Drug Discovery; Drug Liberation; Epoxy Compounds; Inhalation Exposure; Injections, Intramuscular; Male; Mice, Inbred Strains; Microscopy, Electron, Scanning; Phenanthrenes; Rolipram; Surface Properties | 2016 |